Apptly Announces $1,000,000 Non-Brokered Private Placement 
SATO Technologies Corp. Announces Loan Settlement Eliminating All of Its Senior Secured Debt and C$1.5 Million Private Placement 
Theralase(R) Closes C$3.6 Million Brokered Financing NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) — NeuroSigma today announced approval of the Monarch…
NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) — NeuroSigma today announced approval of the Monarch…
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platform WOBURN, Mass., Oct. 03, 2023…
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platform WOBURN, Mass., Oct. 03, 2023…
Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of…
Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of…
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the…
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the…
Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial
Cleared First Three Monotherapy Cohorts with No Dose Limiting Toxicity and No Consistent Pattern of…
Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial
Cleared First Three Monotherapy Cohorts with No Dose Limiting Toxicity and No Consistent Pattern of…
Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
WATERTOWN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
WATERTOWN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
Syneos Health Appoints Colin Shannon as Chief Executive Officer
Industry Veteran Brings Decades of Experience Driving Growth at Global Biopharmaceutical Solutions Organizations MORRISVILLE, N.C.,…
Syneos Health Appoints Colin Shannon as Chief Executive Officer
Industry Veteran Brings Decades of Experience Driving Growth at Global Biopharmaceutical Solutions Organizations MORRISVILLE, N.C.,…
Mosaicx Hosts Webinar with Dr. Anastassia Lauterbach to Unpack Generative AI
Industry experts break down generative AI applications and emerging technology in customer service OMAHA, Neb.,…
Mosaicx Hosts Webinar with Dr. Anastassia Lauterbach to Unpack Generative AI
Industry experts break down generative AI applications and emerging technology in customer service OMAHA, Neb.,…
data.world Integrates with Sigma Computing to Bring Explainability and Trust to Enterprise Data Analytics
The integration enables Sigma users to connect and contextualize disparate data sources for a consolidated,…
data.world Integrates with Sigma Computing to Bring Explainability and Trust to Enterprise Data Analytics
The integration enables Sigma users to connect and contextualize disparate data sources for a consolidated,…
Cognaize Named to the 2023 CB Insights’ Fintech 100 List
Cognaize recognized for achievements in AI and hybrid intelligence for transforming decision-making for financial services…
Cognaize Named to the 2023 CB Insights’ Fintech 100 List
Cognaize recognized for achievements in AI and hybrid intelligence for transforming decision-making for financial services…